首页|预警分级结合集束化干预对急性会厌炎患者临床疗效、并发症的应用价值

预警分级结合集束化干预对急性会厌炎患者临床疗效、并发症的应用价值

Effect of early warning grading combined with bundles of care on clinical efficacy and complications in patients with acute epiglottitis

扫码查看
目的 探讨预警分级结合集束化干预对急性会厌炎患者临床疗效、并发症的应用价值.方法 纳入2022 年进行急性会厌炎治疗的 96 例患者,等数分组法将患者分为对照组(n=50)和研究组(n=46).对照组采用预警分级与常规护理,研究组采用预警分级结合集束化护理.对比 2 组患者护理效果.结果 研究组患者并发症发生率显著小于对照组(P<0.05);研究组患者救治率及护理满意度均高于对照组(P<0.05);研究组患者会厌高度水肿、呼吸困难、吞咽困难、咽喉疼痛改善时间显著低于对照组(P<0.05).结论 急性会厌炎应用预警分级结合集束化护理可显著改善患者的救治率与呼吸困难缓解时间,减少并发症发生率的同时提升护理满意度,值得推广.
Objective To explore the effect of early warning grading combined with bundles of care on clinical efficacy and complications in patients with acute epiglottitis.Methods A total of 96 patients with acute epiglottitis treated in 2022 were recruited.They were divided into the control group(n=50)and study group(n=46)based on the equal number grouping method.The early warning grading was applied to all patients,and routine nursing and bundles of care were respectively applied to patients of control group and study group.Nursing outcomes were compared between groups.Results The incidence of complications after nursing in the study group was significantly lower than that of the control group(P<0.05),while the treatment rate and nursing satisfaction were significantly higher(P<0.05).The time of improvement of severe edema of epiglottis,dyspnea,dysphagia and sore throat was significantly shorter in the study group than that of the control group(P<0.05).Conclusion The early warning grading combined with bundles of care significantly enhances the treatment rate and shortens the time to relieve the dyspnea in patients with acute epiglottitis,which reduces the incidence of complications and enhances the nursing satisfaction,and worthy of clinical application.

early warning gradingbundles of careacute epiglottitissymptom improvement

赵小娟、张燕、李月华、范秀杰、李婧

展开 >

063000 河北省唐山市人民医院耳鼻咽喉头颈外科

063000 河北省唐山市人民医院体检中心

063000 河北省唐山市人民医院心内三内分泌科

063000 河北省唐山市人民医院骨科

展开 >

预警分级 集束化干预 急性会厌炎 症状改善

河北省医学科学研究重点课题计划

20221829

2024

河北医药
河北省医学情报研究所

河北医药

CSTPCD
影响因子:1.075
ISSN:1002-7386
年,卷(期):2024.46(9)
  • 17